Skip to main content
SpringerLink
Log in

Heart Failure

With an Emphasis on Diastolic Heart Failure

  • Chapter
Aging, Heart Disease, and Its Management

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 127 Accesses

Abstract

Until recently, there were almost no data regarding the etiology, pathophysiology, diagnosis, prognosis, and management of older patients with heart failure. Uncertainty as a result of the large gaps in our knowledge, coupled with recognition of the marked public health implications of heart failure among the elderly, lays the foundation for a number of controversies in this area. In order to address these controversies, this chapter will focus on those aspects of heart failure that are particular to the older patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin 1989; 7 (1): 1–9.

    PubMed  CAS  Google Scholar 

  2. Schocken DD. Epidemiology and Risk Factors for Heart Failure in the Elderly, 16(3): 2000, WB Saunders Co., Philadelphia, PA, pp. 407–418.

    Google Scholar 

  3. Kitzman DW, Gardin JM, Gottdiener JS, Arnold AM, Boineau R, Aurigemma GP, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001; 87: 413–419.

    Article  PubMed  CAS  Google Scholar 

  4. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628–1637.

    Article  PubMed  CAS  Google Scholar 

  5. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999; 106: 605–612.

    Article  PubMed  CAS  Google Scholar 

  6. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–639.

    Article  PubMed  CAS  Google Scholar 

  7. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214–1218.

    Article  PubMed  CAS  Google Scholar 

  8. Kramer K, Kirkman P, Kitzman DW, Little WC. Flash pulmonary edema: association with hypertension, reocurrence despite coronary revascularization. Am Heart J 2000; 140: 451–455.

    Article  PubMed  CAS  Google Scholar 

  9. Arnold JMO, Mrachiori GE, Imrie JR, Burton GL, Pflugfelder PW, Kostuk WJ. Large artery function in patients with chronic heart failure. Circulation 1991; 84: 2418–2425.

    Article  PubMed  CAS  Google Scholar 

  10. Luchi RJ, Snow E, Luche JM. Left ventricular function in hospitalized geriatric patients. J Am Geriatr Soc 1982; 30: 700–705.

    PubMed  CAS  Google Scholar 

  11. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.

    Article  PubMed  CAS  Google Scholar 

  12. Ramachandran S, Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33: 1948–1955.

    Article  Google Scholar 

  13. Gottdiener JS, Arnold AM, Marshall RJ, Aurigemma GP, Gardin JM, Rutledge JC, et al. LV function and congestive heart failure in the elderly-relevance of therapeutic trials. The Cardiovascular Health Study. Circulation 1998; 98: S718 (abstract).

    Article  Google Scholar 

  14. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000; 86: 1090–1096.

    Article  PubMed  CAS  Google Scholar 

  15. Kupari M, Lindroos M, Iivanainen AM, Heikkila J, Tilvis R. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 1997; 241: 387–394.

    Article  PubMed  CAS  Google Scholar 

  16. Rich MW, Kitzman DW. Heart failure in octogenarians: a fundamentally different disease. Am J Geriatr Cardiol 2000; 9: 97–104.

    Article  Google Scholar 

  17. Ogawa T, Spina RJ, Martin WH, Kohrt WM, Schechtman KB. Effect of aging, sex, and physical training on cardiovacular responses to exercise. Circulation 1992; 86: 494–503.

    Article  PubMed  CAS  Google Scholar 

  18. The ACC/AHA Task Force on Practice Guidelins (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: executive summary. Circulation 2001; 38: 2002–2113.

    Google Scholar 

  19. Cody R, Toree S, Clar M, Pnodolfina K. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med 1989; 149: 1023–1028.

    Article  PubMed  CAS  Google Scholar 

  20. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan M. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991; 17: 1065–1072.

    Article  PubMed  CAS  Google Scholar 

  21. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, et al. Cardiac cycle dependent changes in aortic area and aortic distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001; 38: 796–802.

    Article  PubMed  CAS  Google Scholar 

  22. Little WC. Enhanced load dependence of relaxation in heart failure: clinical implications. Circulation 1992; 85: 2326–2328.

    Article  PubMed  CAS  Google Scholar 

  23. Hoit BD, Walsh RA. Diastolic dysfunction in hypertensive heart disease. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Lea & Febiger, Philadelphia, PA, 1994, pp. 354–372.

    Google Scholar 

  24. Gelpi RJ. Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs. Circ Res 1991; 68: 555–567.

    Article  PubMed  CAS  Google Scholar 

  25. Shannon RP, Komamura K, Gelpi RJ, Vatner SF. Altered load: an important component of impaired diastolic function in hypertension and heart failure. In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart, 2nd ed. Kluwer Academic, Norwell, MA, 1994, pp. 177–185.

    Chapter  Google Scholar 

  26. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92: 1933–1939.

    Article  PubMed  CAS  Google Scholar 

  27. Little WC, Braunwald E. Assessment of cardiac function. In: Braunwald E, ed. Heart Disease, 5th ed. WB Saunders, Philadelphia, PA, 1996, pp. 421–444.

    Google Scholar 

  28. Iriarte M, Murga N, Morillas M, Salcedo A, Etxebeste J. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 1993; 71: 308–312.

    Article  PubMed  CAS  Google Scholar 

  29. Gandhi SK, Powers JE, Fowle KM, Rankin KM, Nomeir AM, Kitzman DW, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2000; 344: 17–22.

    Article  Google Scholar 

  30. Clarkson PBM, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diatsolic heart failure. Circulation 1996; 93: 2037–2042.

    Article  PubMed  CAS  Google Scholar 

  31. Davis KM, Fish LC, Elahi D, Clark BA, Minaker KL. Atrial natruretic paptide levels in the prediction of congestive heart failure risk in frail elderly. JAMA 1992; 267: 2625–2629.

    Article  PubMed  CAS  Google Scholar 

  32. Bella JN, Palmieri V, Liu JE, Kitzman DW, Oberman A, Hunt SC, et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: the hypertension genetic epidemiology network (hypergen) study. Hypertension 2001; 38: 424–428.

    Article  PubMed  CAS  Google Scholar 

  33. Arnett D, Devereux R, Rao DC, Kitzman DW, Oberman A, Hopkins P. A genome search in hypertensive African American and white siblings detects a locus mapping to chromosome 7 that influences variation in left ventricular mass: the HyperGEN Study. Circulation 1999; 100: 1–193.

    Article  Google Scholar 

  34. Tang W, Arnett DK, Devereux RB, Atwood L, Kitzman DW, Rao DC. Linkage of left ventricular diastolic filling parameters to chromosome 5 in hypertensive African-Americans: the HyperGEN Study. Am J Cardiol 2002; 15: 621–627.

    Google Scholar 

  35. Vikstrom KL, Leinwand LA. The molecular genetic basis of familial hypertrophic cardiomyopathy. Heart Failure 1995; 11: 5–14.

    Google Scholar 

  36. Webster KA, Bishopric NH. Molecular aspects and gene therapy prospects for diastolic failure. Cardiol Clin 2000; 18: 621–635.

    Article  PubMed  CAS  Google Scholar 

  37. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000; 101: 2118–2121.

    Article  PubMed  CAS  Google Scholar 

  38. Yamamoto K, Burnett JC Jr, Bermudez EA, Jougasaki M, Bailey KR, Redfield MM. Clinical criteria and biochemical markers for the detection of systolic dysfunction (in process citation). J Card Failure 2000; 6: 194–200.

    Article  CAS  Google Scholar 

  39. Ghali JK, Kadakia S, Cooper R, Liao Y. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure. Am J Cardiol 1991; 67: 1002–1006.

    Article  PubMed  CAS  Google Scholar 

  40. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527–1533.

    Article  PubMed  CAS  Google Scholar 

  41. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19: 990–1003.

    Article  Google Scholar 

  42. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001; 104: 779–782.

    Article  PubMed  CAS  Google Scholar 

  43. Davis KM, Fish LC, Minaker KL, Elahi D. Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease. J Gerontol 1996; 51A: M95 - M101.

    CAS  Google Scholar 

  44. Kitzman DW. Heart failure in the elderly: systolic and diastolic dysfunction. Am J Geriatr Cardiol 1995; 5: 20–26.

    Google Scholar 

  45. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290–1295.

    PubMed  CAS  Google Scholar 

  46. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney R. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190–1195.

    Article  PubMed  CAS  Google Scholar 

  47. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99–104.

    Article  PubMed  CAS  Google Scholar 

  48. Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL. Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 1999; 107: 549–555.

    Article  PubMed  CAS  Google Scholar 

  49. Pernenkil R, Vinson JM, Shah AS, Beckham V, Wittenberg C, Rich MW. Course and prognosis in patients ≥70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79: 216–219.

    Article  PubMed  CAS  Google Scholar 

  50. Rich MW, Vinson JM, Sperry JC, Shah AS, Spinner LR, Chung MK, et al. Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med 1993; 8: 585–590.

    Article  PubMed  CAS  Google Scholar 

  51. Kitzman DW, Brubaker PH, Anderson RT, Brosnihan B, Stewart KP, Wesley DJ, et al. Isolated diastolic heart failure: does it exist? Characterization of an important syndrome among the elderly. J Am Coll Cardiol 2000; 35: 193A.

    Google Scholar 

  52. Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population (see comments). Arch Intern Med 1999; 159: 505–510.

    Article  PubMed  CAS  Google Scholar 

  53. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301–306.

    Article  PubMed  CAS  Google Scholar 

  54. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period (see comments). Arch Intern Med 1999; 159: 29–34.

    Article  PubMed  CAS  Google Scholar 

  55. Marshall RJ, Gottdiener JS, Shemanski L, McClelland MS, Furberg C, Kitzman DW, et al. Outcome of congestive heart failure in the elderly: influence of left ventricular systolic function. The Cardiovascular Health Study. Circulation 1998; I - 17: 1064.

    Google Scholar 

  56. Taffet GE, Teasdale TA, Bleyer AJ, Kutka NJ, Luchi RJ. Survival of elderly men with congestive heart failure. Age Ageing 1992; 21: 49–55.

    Article  PubMed  CAS  Google Scholar 

  57. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 1990; 66: 1257–1259.

    Article  PubMed  CAS  Google Scholar 

  58. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, et al. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 2000; 85: 1110–1113.

    Article  PubMed  CAS  Google Scholar 

  59. Davies LC, Francis DP, Piepoli M, Scott AC, Ponikowski P, Coats A. Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 2000; 83: 147–151.

    Article  PubMed  CAS  Google Scholar 

  60. Krumholz HM, Wang Y, Parent EM, Modena MG, Petrillo M, Radford MJ. Quality of Care for elderly patients hospitalized with heart failure. Arch Intern Med 1997; 157: 2242–2247.

    Article  PubMed  CAS  Google Scholar 

  61. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 1999; 354: 1077–1083.

    Article  PubMed  CAS  Google Scholar 

  62. Stewart S, Vanderheyden M, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med 1999; 159: 257–261.

    Article  PubMed  CAS  Google Scholar 

  63. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum A Jr, Barretto AC, Carvalho AC, et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 2001; 161: 2337–2342.

    Article  PubMed  CAS  Google Scholar 

  64. Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999; 159: 1939–1945.

    Article  PubMed  CAS  Google Scholar 

  65. Whellan DJ, Gaulden L, Gattis WA, Granger B, Russell SD, Blazing MA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 2001; 161: 2223–2228.

    Article  PubMed  CAS  Google Scholar 

  66. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48: S101 - S109.

    PubMed  CAS  Google Scholar 

  67. Baker R, Wu AW, Teno JM, Kreling B, Damiano AM, Rubin HR, et al. Family satisfaction with endof-life care in seriously ill hospitalized adults. J Am Geriatr Soc 2000; 48: S61 - S69.

    PubMed  CAS  Google Scholar 

  68. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999; 84: 611–612.

    Article  PubMed  CAS  Google Scholar 

  69. Philbin EF. Current community practices in heart failure: understanding the underutilization of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1997;29(2 (Suppl A):325.

    Google Scholar 

  70. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; I (8442): 1349–1354.

    Article  Google Scholar 

  71. Dahlof B, Lindholm L, Hannson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281–1285.

    Article  PubMed  CAS  Google Scholar 

  72. Stassen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757–764.

    Article  Google Scholar 

  73. Gong LS, Zhang W, Zhu Y. Shanghai Trial of Nifedipine in the Elderly (STONE). J Hypertens 2001; 14: 1237–1245.

    Article  Google Scholar 

  74. Braunwald E. Ace inhibitors-a cornerstone of the treatment of heart failure. N Engl J Med 1991; 325: 351–353.

    Article  PubMed  CAS  Google Scholar 

  75. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450–1456.

    Article  PubMed  CAS  Google Scholar 

  76. Flather M, Yusuf S, Kober L, Pfeffer M, Hall A, Murphy G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355: 1575–1581.

    Article  PubMed  CAS  Google Scholar 

  77. Kitzman DW. Heart failure and cardiomyopathy. In: Abrams WB, Beers MH, Berkow B, eds. The Merck Manual of Geriatrics, 3rd ed. Merck Research Laboratories, Whitehouse Station, NJ, 2000, pp. 900–914.

    Google Scholar 

  78. Packer M, Poole-Wilson PA, Armstrong PW, Cleland J, Horowitz JD, Massie BM, et al., and on behalf of the ATLAS study group. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart disease. Circulation 1999; 100: 2312–2318.

    Article  PubMed  CAS  Google Scholar 

  79. Pitt B, Segal R, Martinez FA, Meurer G, Cowley A, Thomas I, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747–752.

    Article  PubMed  CAS  Google Scholar 

  80. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-The Losartan Heart Failure Survival Study (ELITE II). Lancet 2000; 355: 1582–1587.

    Article  PubMed  CAS  Google Scholar 

  81. Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 1999; 99: 990–992.

    Article  PubMed  CAS  Google Scholar 

  82. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, ProbstfieldJ, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 1999; 100: 1056–1064.

    Article  PubMed  CAS  Google Scholar 

  83. Cohn JN, Johnson GR, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310.

    Article  PubMed  CAS  Google Scholar 

  84. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chornic heart failure. N Engl J Med 1996; 334: 1349–1355.

    Article  PubMed  CAS  Google Scholar 

  85. Anon. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001–2007.

    Article  Google Scholar 

  86. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9–13.

    Article  Google Scholar 

  87. Digoxin Investigators Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525–533.

    Article  Google Scholar 

  88. Rich MW, McSherry F, Williford WO, Yusuf S. Effect of age on mortality, hospitalizations, and response to digoxin in patients with heart failure: the DIG Study. J Am Coll Cardiol 2001; 38: 806–813.

    Article  PubMed  CAS  Google Scholar 

  89. Ware JA, Snow E, Luchi JM, Luchi RJ. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure. J Am Geriatr Soc 1984; 32: 631–635.

    PubMed  CAS  Google Scholar 

  90. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997; 29: 1206–1213.

    Article  PubMed  CAS  Google Scholar 

  91. Cody R, Pitt B, Perez A, Betz P, for the RALES Investigators. The benefit of spironolactone in the RALES Trial is not primarily due to a diuretic effect. J Am Coll Cardiol 2000; 35: 212A.

    Google Scholar 

  92. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709–717.

    Article  PubMed  CAS  Google Scholar 

  93. Berry C, McMurray JJ. Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart 2001; 85: E8.

    Article  PubMed  CAS  Google Scholar 

  94. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 1994; 128: 564–574.

    Article  PubMed  CAS  Google Scholar 

  95. Kitzman DW. Therapy for diastolic heart failure: on the road from myths to multicenter trials. J Card Failure 2001; 7: 229–231.

    Article  CAS  Google Scholar 

  96. Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc 1995; 43: 1035–1042.

    PubMed  CAS  Google Scholar 

  97. Committee on Evaluation and Management of Heart Failure. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995; 26: 1376–1398.

    Article  Google Scholar 

  98. Fleg J, Kitzman DW, Aronow WS, Rich MW, Gardin JM, Slone S. Physician management of patient with heart failure and normal versus decreased left ventricular systolic function. Am J Cardiol 1998; 81: 506–509.

    Article  PubMed  CAS  Google Scholar 

  99. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol 1994; 73: 1105–1111.

    Article  PubMed  CAS  Google Scholar 

  100. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989; 13: 36–45.

    Article  PubMed  CAS  Google Scholar 

  101. Olson LJ, Gertz MA, Edwards WD, et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987; 317: 738–742.

    Article  PubMed  CAS  Google Scholar 

  102. Hansson L, Lindholm L, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in Swedish Trial in Old Patients with Hypertension-2 Study. Lancet 1999; 354: 1751–1756.

    Article  PubMed  CAS  Google Scholar 

  103. The Allhat Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967–1975.

    Article  Google Scholar 

  104. Lorell BH, Grossman W Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol 1987; 9: 1189–1193.

    Article  PubMed  CAS  Google Scholar 

  105. Lorell BH. Cardiac renin-angiotensin system in cardiac hypertophy and failure. In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart, 2nd ed. Kluwer Academic, Norwell, MA, 1996, pp. 91–99.

    Google Scholar 

  106. Oren S, Grossman E, Frohlich ED. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisionopril, or fosenopril. Am J Cardiol 1996; 77: 93–96.

    Article  PubMed  CAS  Google Scholar 

  107. Friedrich SP, Lorell BH, Douglas PS, et al. Intracardiac ACE inhibition improves diastolic distensibility in patients with left ventricular hypertophy due to aortic stenosis. Circulation 1992; 86 (Suppl I): I - 119.

    Google Scholar 

  108. Lakatta E. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999; 47: 613–625.

    PubMed  CAS  Google Scholar 

  109. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993; 71: 602–604.

    Article  PubMed  CAS  Google Scholar 

  110. Philbin EF, Rocco TA. The utility of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 1997;29(2 (Suppl A):321.

    Google Scholar 

  111. Dauterman KW, Go AS, Rowell R, Gebretsadik T, Gettner S, Massie BM. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Failure 2001; 7: 221–228.

    Article  CAS  Google Scholar 

  112. Cleland JG, Tendera M, Adamus J, Freemantle N, Gray CS, Lye M, et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators (see comments). Eur J Heart Failure 1999; 1: 211–217.

    Article  CAS  Google Scholar 

  113. Abraham TP, Kon ND, Nomeir AM, Cordell AR, Kitzman DW. Accuracy of transesophageal echocardiography in preoperative determination of aortic anulus size during valve replacement. J Am Soc Echocardiogr 1997; 10: 149–154.

    Article  PubMed  CAS  Google Scholar 

  114. Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, et al. Candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. J Card Failure 1999; 5 (3): 276–282.

    Article  CAS  Google Scholar 

  115. Vandenberg VF, Rath LS, Stuhlmuller P, Melton H, Skorton DJ. Estimation of left ventricular cavity area with on-line, semiautomated echocardiographic edge detection system. Circulation 1992; 86: 159–166.

    Article  PubMed  CAS  Google Scholar 

  116. Bonow RO, Leon MB, Rosing DR, Kent K, Lipson LC, Bacharach SL, et al. Effects of verapamil and propranolol on left ventricular systolic function and diatsolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 1981; 65: 1337–1350.

    Article  Google Scholar 

  117. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short-and long-term effects. Circulation 1985; 72: 853–864.

    Article  PubMed  CAS  Google Scholar 

  118. Udelson J, Bonow RO. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy. In: Gaasch WH, ed. Left Ventricular Diastolic Dysfunction and Heart Failure. Lea and Febiger; Malvern, PA, 1996, pp. 465–489.

    Google Scholar 

  119. Serizawa T, Shin-Ichi M, Nagai Y, Ogawa T, Sato T, Nezu Y, et al. Diastolic abnormalities in low-flow and pacing tachycardia-induced ischemia in isolated rat hearts-modification by calcium antagonists. In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart, 2nd ed. Kluwer Academic, Norwell, MA, 1996, pp. 266–274.

    Google Scholar 

  120. Cheng CP, Pettersson K, Little WC. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure. J Pharmacol Exp Thera 1994; 271: 1409–1417.

    CAS  Google Scholar 

  121. Cheng CP, Noda T, Ohno M, Little WC. Differential effects of enalaprilat and felodipine on diastolic function during exercise in dogs with congestive heart failure. Circulation 1993; 88 (4): I - 294.

    Google Scholar 

  122. Little WC, Cheng CP, Elvelin L, Nordlander M. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. Cardiovasc Drugs Ther 1995; 9: 657–663.

    Article  PubMed  CAS  Google Scholar 

  123. Ten Cate FJ, Serruys PW, Mey S, Roelandt JR. Effects of short-term administration of verapamil on left ventricular filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation 1983; 68: 1274–1279.

    Article  Google Scholar 

  124. Hess OM, Murakami T, Krayenbuehl HP. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation 1996; 74: 530–543.

    Article  Google Scholar 

  125. Brutsaert DL, Rademakers F, Sys SU, Gillebert TC, Housmans PR. Analysis of relaxtion in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis 1985; 28: 143–163.

    Article  PubMed  CAS  Google Scholar 

  126. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993; 22: 318–325.

    Article  PubMed  CAS  Google Scholar 

  127. Setaro JF, Zaret BL, Schulman DS, Black HR. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance Am J Cardiol 1990; 66: 981–986.

    CAS  Google Scholar 

  128. Sasayama S, Asanoi H, Ishizaka S, Kihara Y. Diastolic dysfunction in experiemental heart failure. In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart, 2nd ed. Kluwer Academic, Norwell, MA, 1994, pp. 195–202.

    Chapter  Google Scholar 

  129. Colucci WS, Ribeiro JP, Rocco MB, Quigg RJ, Creager MA, Marsh JD, et al. Impaired chronotropic response to exercise in patients wtih congestive heart failure. Circulation 1989; 80: 314–323.

    Article  PubMed  CAS  Google Scholar 

  130. Udelson J, Bonow RO. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Lea and Febiger, Philadelphia, PA, 1994, pp. 462–489.

    Google Scholar 

  131. Cheng CP, Igarashi Y, Little WC. Mechanism of augmented rate of left ventricle filling during exercise. Circ Res 1992; 70: 9–19.

    Article  PubMed  CAS  Google Scholar 

  132. Cheng CP, Noda T, Nozawa T, Little WC. Effect of heart failure on the mechanism of exercise induced augmentation of mitral valve flow. Circ Res 1993; 72: 795–806.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Dalane W. Kitzman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Niloo M. Edwards MD

  2. Division of Circulatory Physiology/Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mathew S. Maurer MD

  3. University of Connecticut School of Medicine, Farmington, CT, USA

    Rachel B. Wellner BA, MPH

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Kitzman, D.W. (2003). Heart Failure. In: Edwards, N.M., Maurer, M.S., Wellner, R.B. (eds) Aging, Heart Disease, and Its Management. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-357-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-357-6_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9766-3

  • Online ISBN: 978-1-59259-357-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation